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The axe–txe operon encodes a toxin–antitoxin (TA) pair, Axe–Txe, that was initially identified on
the multidrug-resistance plasmid pRUM in Enterococcus faecium.I nEscherichia coli, expression
of the Txe toxin is known to inhibit cell growth, and co-expression of the antitoxin, Axe, counteracts
the toxic effect of Txe. Here, we report the nucleotide sequence of pS177, a 39 kb multidrug-
resistant plasmid isolated from vancomycin-resistant Ent. faecium, which harbours the axe–txe
operon and the vanA gene cluster. RT-PCR analysis revealed that the axe–txe transcript is
produced by strain S177 as well as by other vancomycin-resistant enteroccoci. Moreover, we
determine the mechanism by which the Txe protein exerts its toxic activity. Txe inhibits protein
synthesis in E. coli without affecting DNA or RNA synthesis, and inhibits protein synthesis in a
cell-free system. Using in vivo primer extension analysis, we demonstrate that Txe preferentially
cleaves single-stranded mRNA at the first base after an AUG start codon. We conclude that Txe
is an endoribonuclease which cleaves mRNA and inhibits protein synthesis.
INTRODUCTION
Enterococcal species such as Enterococcus faecium and
Enterococcus faecalis have emerged as significant nosoco-
mial pathogens throughout Europe and the United States.
These bacteria are increasingly responsible for a variety of
illnesses, particularly in immunocompromised patients,
and are one of the main causes of surgical-site infections
(Hidron et al., 2008; Owens & Stoessel, 2008; Richards
et al., 2000). Clinical isolates of enterococci are often resis-
tant to multiple antibiotics either intrinsically or through
the lateral gene transfer of antibiotic resistance determi-
nants, the most problematic of which are the genetic
elements that encode vancomycin resistance (Baldassarri
et al., 2005; Deshpande et al., 2007; Dowzicky & Park, 2008;
Guardabassi & Dalsgaard, 2004; Low et al., 2001; Sader &
Jones, 2009; Werner et al., 2008). A recent survey of Gram-
positive pathogens isolated from hospitals in the United
States found that, for between 2002 and 2008, up to 33%
of enterococcal species tested as part of the surveillance
network were vancomycin-resistant enterococci (VRE)
(JMI, 2009). As vancomycin is a preferred antimicrobial
treatment for enterococcal infections, the increasing occur-
rence of multidrug-resistant VRE severely limits thera-
peutic options and highlights the need for new antibiotics.
In the search for novel antimicrobial agents, one intriguing
approach involves the explicit targeting of toxin–antitoxin
(TA) systems to exploit their innate toxicity (DeNap &
Hergenrother, 2005; Engelberg-Kulka et al., 2004; Williams
& Hergenrother, 2008). TA genes were originally discov-
ered on plasmids, where they function as plasmid main-
tenance systems (Ogura & Hiraga, 1983). In plasmids
containing the genes for proteic (type II) TA systems, a
stable toxin and a labile antitoxin are encoded in a single
operon. In a cell carrying the plasmid, both proteins are
expressed and the antitoxin binds to and inhibits the toxin.
However, if during cell division a plasmid-free segregant
arises, the labile antitoxin is rapidly degraded, freeing the
Abbreviations: PNK, polynucleotide kinase; TA, toxin–antitoxin; TCA,
trichloroacetic acid; VRE, vancomycin-resistant enterococci.
The GenBank/EMBL/DDBJ accession number for the sequence of
plasmid pS177 reported in this paper is HQ115078.
Three supplementary figures, showing protein synthesis following IPTG
induction of Txe–His6, Axe–His6 and empty pET21a vector, and the
effect of Txe–His6 expression in Escherichia coli Rosetta BL21(DE3),
are available with the online version of this paper.
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045492 G 2011 SGM Printed in Great Britain 387toxin to kill the cell (Aizenman et al., 1996; Hayes, 2003).
This post-segregational killing has led TA systems to be
dubbed ‘plasmid addiction’ systems, as the cell will die if
the plasmid is lost (Gerdes et al., 1986). The first TA system
identified was ccdAB, on the F plasmid of Escherichia coli
(Ogura & Hiraga, 1983), and since its discovery, a number
of TA systems have been identified on a variety of plasmids
and bacterial chromosomes (Moritz & Hergenrother,
2007a; Pandey & Gerdes, 2005; Sletvold et al., 2007).
Among the type II TA systems, the toxins can be grouped
into several superfamilies based on sequence and structural
homology, including the RelE/ParE, MazF/CcdB, Doc,
HipA, f and PIN domain superfamilies, and most have
been shown to act as either endoribonucleases (also
termed mRNA interferases) or inhibitors of DNA gyrase
(Anantharaman & Aravind, 2003; Bernard & Couturier,
1992; Christensen-Dalsgaard & Gerdes, 2008; Christensen-
Dalsgaard et al., 2008; Fico & Mahillon, 2006; Francuski &
Saenger, 2009; Jiang et al., 2002; Makarova et al., 2009;
Miallau et al., 2009; Van Melderen, 2002).
Reports of TA systems in Gram-positive bacteria have been
much rarer compared with the numerous studies of TA
systems in Gram-negative bacteria. One of the first proteic
TA systems described in a Gram-positive organism was the
Axe–Txe system, which was identified on the 24.8 kb non-
conjugative plasmid pRUM, obtained from a multidrug-
resistant clinical isolate of Ent. faecium (Grady & Hayes,
2003). pRUM confers resistance to chloramphenicol,
erythromycin, streptomycin and streptothricin, and coex-
ists in its host with a 60 kb conjugative vancomycin
resistance plasmid. Sequence analysis of pRUM suggested it
arose from a variety of mobile genetic elements, recomb-
ination events and smaller plasmids (Grady & Hayes,
2003). Although it was originally described in 2003, there
have been no further reports on the biochemical char-
acterization of Axe–Txe.
We have previously shown that in a collection of 75 VRE
clinical isolates, 56 contained the genes for axe–txe,a s
determined by PCR analysis (Moritz & Hergenrother,
2007a). Of those 56 isolates, gel extractions and conjugative
matings suggested a physical linkage between the vanco-
mycin-resistance genes and the axe–txe genes in 44 isolates
(Moritz & Hergenrother, 2007a). Recently, a separate
analysis of a collection of Ent. faecium isolates found that of
42 strains positive by PCR for the pRUM replicon type,
90% were also PCR-positive for axe–txe (Rosvoll et al.,
2010). Additionally, co-hybridization studies suggested
that a genetic linkage existed between the pRUM replicon
and the axe–txe genes (Rosvoll et al., 2010). Thus, the axe–
txe genes appear to be common features of plasmids in
enterococci where they may play a role in the persistence
and stability of plasmid-encoded antibiotic resistance,
including vancomycin resistance.
Although several TA systems have been well characterized
biochemically, many of these were discovered on the
chromosomes of Gram-negative bacteria (Christensen
et al., 2001; Engelberg-Kulka & Glaser, 1999). In contrast,
there is a relative paucity of studies on TA systems of
Gram-positive origin, and TA systems that were discovered
on multidrug resistance plasmids. As the dissemination of
such plasmids enables widespread resistance to antibiotics,
the mechanisms by which these plasmids maintain them-
selves in their hosts are of critical importance. The
development of toxin activation strategies for Gram-
positive bacteria requires the identification of a suitable
TA system that is functional in these hosts, and informa-
tion about the mechanism of action of the toxin.
In this study, we report the nucleotide sequence of plasmid
pS177 (39023 bp), isolated from the vancomycin-resistant
Ent. faecium clinical isolate S177. pS177 confers resistance
to kanamycin, streptothricin, streptomycin, erythromycin
and vancomcyin and harbours the genes for axe–txe and a
relBE homologue, relBEEf. Additionally, we confirmed by
RT-PCR analysis that the axe–txe transcript is synthesized
in six VRE clinical isolates, including strain S177. Although
axe–txe has been shown to function as a plasmid
stabilization system in Ent. faecium, Bacillus thuringiensis
and E. coli (Grady & Hayes, 2003), the mechanism by
which Txe elicits its toxic effect on the cell is unknown.
Here, we demonstrate that expression of the toxin inhibits
protein synthesis in the cell but does not affect DNA or
RNA synthesis. Primer extension analysis reveals that Txe is
an endoribonuclease that cleaves cellular RNA three bases
downstream of an AUG start codon. This is the first report,
to our knowledge, of the biochemical mode of action of
Txe, and one of the few studies on TA systems of Gram-
positive origin.
METHODS
Plasmid DNA isolation. PlasmidDNA wasisolatedfromEnt.faecium
by using a modified alkaline lysis midiprep protocol (Sambrook &
Russell, 2001). A 50 ml bacterial culture grown in brain heart infusion
broth was harvested after 12–14 h growth and the pellet was
resuspended in 2 ml solution I (25 mM Tris, pH 8.0, 50 mM glucose,
10 mM EDTA) and 200 ml lysozyme (100 mg ml
21 in 25 mM Tris,
pH 8.0). The suspension was incubated at 37 uC for 1 h. Solution II
(3 ml; 0.2 M NaOH, 1% SDS) was added and the tube was inverted
gently six times, followed by 4.5 min incubation on ice. Finally, 3 ml
solution III (5 M potassium acetate, 11.5% glacial acetic acid) was
added and the tube was inverted eight times, followed by 5 min
incubation on ice. Cell debris was collected by centrifuging for 20 min
at 20000 g at 4 uC. To extract the nucleic acid, 7 ml supernatant was
transferred to a new tube and an equal volume of phenol/chloroform/
isoamyl alcohol (25:24:1, w/v/v) was added and the tube was shaken
vigorously, followed by centrifugation as described previously. Nucleic
acid was precipitated from 6 ml of the aqueous layer by adding an
equal volume of 2-propanol and incubating at room temperature for
2 min, followed by centrifuging for 30 min at 27000 g. The nucleic
acid pellet was washed with 5 ml 70% ethanol and centrifuged for
10 min at 27000 g at 4 uC. All ethanol was removed and the pellet was
allowed to air-dry, then dissolved in 100 ml 10 mM Tris, pH 8.0,
overnight at 4 uC. The RNA was digested by incubation with 5 ml
10 mg RNase A ml
21 for 30 min at 37 uC.
Plasmid DNA isolated from Ent. faecium S177 was separated by
electrophoresis in a 0.65% agarose gel, containing 0.5 mg ethidium
E. M. Halvorsen and others
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21. The dominant supercoiled plasmid band was excised
from the gel and the DNA was recovered by electroelution, following
a modification of the protocol described by Strong et al. (1997).
Dialysis tubing with a 12–14 kDa nominal molecular mass cut-off
(Spectra/Por) was prepared by boiling in 25 mM EDTA, pH 8.0, for
15 min, rinsed thoroughly in dH2O, and rinsed in 16 Tris-acetate-
EDTA (TAE) at 4 uC. The gel slice and approximately 2 ml 16 TAE
were secured in the dialysis tubing and electrophoresed in 16 TAE at
70 V for 2 h, at which point the polarity was reversed for 2 min.
Without removing the gel slice, the solution was subjected to dialysis
against 10 mM Tris, pH 8.0, overnight at 4 uC. The electroeluted
plasmid DNA was concentrated by centrifuging at 500 g in a 0.5 ml
30 kDa molecular mass cut-off tube (Microcon) until the volume was
reduced to 100 ml.
Plasmid DNA sequencing. Shotgun cloning, sequencing and
assembly of plasmid pS177 was performed by the University of
Illinois W.M. Keck Center for Comparative and Functional
Genomics. Briefly, DNA was sheared with a nebulizer, end-repaired
and dephosphorylated. The DNA was separated by electrophoresis in
a 0.8% low-melting-point agarose gel, from which DNA ranging
from 1.5 to 5.0 kb was purified and cloned into the pSMART-HCKan
vector (Lucigen) according to the manufacturer’s instructions.
Sequencing was performed on 480 subclones from both the 59 and
the 39 ends of the insert by using ABI Big-Dye terminator chemistry
(Applied Biosystems). Custom primers were used in PCRs and
sequencing reactions to close gaps and to ensure at least 36 coverage
at each nucleotide (average coverage was 12.46). Sequence data
were assembled by using the Phrap (http://www.phrap.org) and
Sequencher (GeneCodes) software programs. Analysis of the
assembled plasmid via the BLAST program (Altschul et al., 1990) was
used to determine sequence similarity, and annotations were made
accordingly.
Plasmid construction. To construct plasmid pET21a-txe-His6, the
txe gene was amplified by PCR with primers txe-NheI-F, 59-
CATCCCGCTAGCATGATTAAGG-39, and txe-XhoI-R, 59-CGCCC-
TCGAGTTCATAGTG-39. The PCR product was digested with NheI
and XhoI and inserted into pET21a (Novagen) digested with NheI and
XhoI. His6–Txe is expressed from pET21a-txe-His6 upon addition of
IPTG to E. coli Rosetta BL21(DE3).
To construct plasmid pACYCDuet1-His6-axe, the axe gene was
amplified by PCR with primers axe-start-EcoRI, 59-GGGTGAATT-
CAATGGAAGCA-39, and axe-stop-SalI, 59-TCAGACTGCGACTT-
AATCATC-39. The PCR product was digested with EcoRI and SalI
and inserted into pACYCDuet1 (Novagen) digested with EcoRI and
SalI. His6–Axe is expressed from pACYCDuet1-His6-axe upon
addition of IPTG to E. coli BL21(DE3) or Rosetta BL21(DE3).
To construct plasmid pET21a-axe-His6, the axe gene was amplified by
PCR with primers axe-cterm-F1, 59-CCAGGATCCGCATATGAT-
GGAAGC-39, and axe-XhoI-R, 59-CAAGCTCGAGGACTTCATCA-
TC-39. The PCR product was digested with NdeI and XhoI and
inserted into pET21a (Novagen) digested with NdeI and XhoI. Axe–
His6 is expressed from pET21a-axe-His6 upon addition of IPTG to E.
coli BL21(DE3) or Rosetta BL21(DE3).
To construct plasmid pET28a-relB-His6, relB was amplified by PCR
with primers relB-NcoI-F2, 59-GGAGATATACCATGGGAACAAT-
GG-39, and relB-HindIII-R, 59-CCAGAAAAGCTTCCATCCGAGT-
TC-39. The PCR product was digested with NcoI and HindIII and
inserted into pET28a treated with NcoI and HindIII. pET28a-relBE-
His6 produces RelB–His6 upon addition of IPTG to E. coli
BL21(DE3).
To construct plasmid pRSF-1b-His6-lpp, the lpp gene was amplified
by PCR with primers lpp-1-BamHI, 59-CCCCGGATCCGGAGATTA-
ACTCAATCTAGAGG-39, and lpp-2-SalI, 59-CCCCGTCGACGCG-
CCATTTTTCACTTCACAG-39. The PCR product was digested with
BamHI and SalI and inserted into pRSF-1b (Novagen) digested with
BamHI and SalI. His6–Lpp is expressed from pRSF-1b-His6-lpp upon
addition of IPTG to E. coli Rosetta BL21(DE3) or E. coli BL21(DE3)
cells.
Macromolecular synthesis assays. For each strain tested, an
overnight culture grown in Luria–Bertani (LB) with 100 mg ampicillin
ml
21 was used to seed 10 ml filter-sterilized M9 broth (42 mM
Na2HPO4,2 4 m MK H 2PO4, 9 mM NaCl, 19 mM NH4Cl, 0.5%
glucose, 1% Casamino acids) and shaken at 37 uC until an OD600 of
0.3 was reached. To measure protein synthesis, [
3H]leucine (L-[3, 4,
5-
3H(N)]leucine; PerkinElmer) was added to the culture at a final
concentration of 2 mCi ml
21 (74 kBq ml
21) and shaken at 37 uC for
5 min. To measure DNA synthesis, [
3H]thymidine ([6-
3H]thymidine;
PerkinElmer) was added to the culture at a final concentration of
0.1 mCi ml
21 (3.7 kBq ml
21) and shaken at 37 uC for 1 min. To
measure RNA synthesis, [
3H]uridine ([5,6-
3H]uridine; PerkinElmer)
was added to the culture at a final concentration of 0.1 mCi ml
21
(3.7 kBq ml
21) and shaken at 37 uC for 1 min.
Before inducing expression, 0.5 ml was taken from the culture and
added to 1 ml cold 15% trichloroacetic acid (TCA), inverted once
and placed on ice for at least 30 min to precipitate (via TCA) all
macromolecules in the cell. The remaining culture was split in two;
one half received 0.05 mM IPTG and the other received no IPTG. The
cultures were shaken again at 37 uC and aliquots were TCA-
precipitated, as above, 60, 120 and 180 min after IPTG was added.
Precipitates were filtered on a glass microfibre disc (Whatman or
Fisher Scientific), washed twice with cold 100% ethanol and allowed
to dry overnight. Discs were placed in scintillation fluid and c.p.m.
was measured.
Cell-free protein synthesis assays. The S30 T7 high-yield protein
expression system (Promega) was used for cell-free protein synthesis
according to the manufacturer’s protocol with some modifications.
The construct encoding the protein of interest, namely pET21-txe-
His6, pET21a-axe-His6 or pET21a-His6-axe, was incubated with 10 ml
S30 Premix Plus and 9 ml T7 S30 extract (at 37 uC for 20 min) to
allow synthesis of Txe–His6, Axe–His6 or His6–Axe. After the initial
20 min of incubation, 300 ng DNA (10 mM Tris/HCl, pH 8.0)
encoding the reporter protein (pET28a-relB-His6 or pRSF1b-His6-
lpp) was added and shaken at 37 uC for 1 h. Reactions were stopped
by placing tubes on ice for 5 min and by adding 1 mg RNase A to each
tube and incubating at room temperature for 5 min.
Protein was isolated from each reaction by precipitation with cold
10% TCA, followed by centrifugation at 21130 g for 15 min at room
temperature. Pellets were washed with cold 100% ethanol and
allowed to air-dry. Pellets were resuspended in 30 ml 50 mM Tris/
HCl, pH 8.0, 300 mM NaCl and 20 ml6 6 SDS loading dye and
heated at 95 uC for 5 min. For each sample, the entire volume was
run on a 15% polyacrylamide Tris/HCl precast gel (Bio-Rad). After
SDS-PAGE, proteins were transferred to an Immobilon-P PVDF
membrane (Millipore) in cold Towbin transfer buffer. Membranes
were blocked with PBS containing 5% BSA and 0.05% Tween-20
overnight with gentle shaking at 4 uC. Membranes were probed with
HisProbe–HRP (Pierce) at 1 mgm l
21 in PBS with 0.05% Tween-20
for 1 h at room temperature. Antibody binding was detected with
Supersignal West Pico chemiluminescent substrate (Pierce), followed
by exposure to autoradiography film.
RNA extraction and RT-PCR analysis. Total RNA from enter-
ococci was isolated in a manner identical to the extraction method
described previously (Moritz & Hergenrother, 2007a). Intragenic
primers used for axe–txe RT-PCR analysis were designed from the
sequence of the plasmid pRUM. The primers used were axe-txe-RT-F,
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GTTCATCTGTAATTCTTCTGGACC-39. Control primers were based
on the tuf gene specific to enterococcal species (Garcia-Migura et al.,
2007). The primers used were Ent-tuf F, 59-TACTGACAAACCAT-
TCATGATG-39, and Ent-tuf R, 5-9AACTTCGTCACCAACGCG-
AAC-39. RT-PCR and PCR for DNA contamination were performed
by using the SuperScript One-Step RT-PCR with Platinum Taq kit
(Invitrogen) as described previously (Moritz & Hergenrother, 2007a).
RT-PCR amplification products were analysed by agarose gel
electrophoresis in1% agarose and werestainedwithethidiumbromide.
Primer extension analysis. Primer lpp 21 (59-CTGAACGTCA-
GAAGACAGCTGATCG-39) (Christensen et al., 2003) was 59-end-
labelled with [c-
32P]ATP according to a modification of the protocol
reported by Kitami & Hiwada (1999). In a 10 ml reaction volume,
10 pmol of the lpp 21 primer was mixed with 1 ml1 0 6 T4
polynucleotide kinase (PNK) reaction buffer (NEB), 1 ml1 0UT 4
PNK (NEB) ml
21 and 3 ml [c-
32P]ATP [6 mCi mmol
21 (222 MBq
mmol
21), 10 mCi ml
21 (370 MBq ml
21) or adjusted appropriately
for decay]. The reaction mixture was incubated at 37 uC for 30 min
followed by 2 min at 90 uC to inactivate the enzyme. Unincorporated
nucleotides were removed with a NucAway Spin column according to
the manufacturer’s protocol (Ambion). The final concentration of the
end-labelled primer was adjusted to 100 fmol ml
21 with RNase-free
dH2O.
The DNA sequencing ladder was prepared with the primer lpp 21 and
pRSF-1b-His6-lpp as template to map the 59-end of the lpp mRNA.
Sequencing reactions were prepared by using the Sequenase version
2.0 DNA sequencing kit and [a-
32P]dATP according to the manu-
facturer’s protocol (USB).
E. coli Rosetta BL21(DE3) carrying pET21-txe-His6 was grown in LB
containing 100 mg ampicillin ml
21 to an OD600 of 0.3. Before adding
0.5 mM IPTG, a 1 ml aliquot was centrifuged for 5 min at room
temperature and the pellet was frozen at 280 uC. Following addition
of IPTG, aliquots were also taken at 30, 60 and 120 min post-
induction. RNA was extracted by using the RNeasy mini kit for
isolation of total RNA from bacteria and treated with RNase-free
DNase (Qiagen). The
32P-labelled lpp 21 primer was hybridized with
10 mg total RNA from each time point according to a modification of
the protocol reported by Kitami & Hiwada (1999). In a 40 ml reaction
volume, 10 mg total RNA, 200 fmol
32P-labelled lpp 21 primer, 4 ml
106 avian Myeloblastosis virus reverse transcriptase (AMV RT)
reaction buffer (NEB) and 4 ml1 0 6 dNTP solution (10 mM each
dNTP) were added together. The reaction mixture was heated at
90 uC for 2 min and then incubated at 54 uC overnight (18–20 h).
The next day, 20 ml of a primer extension mastermix (6 ml1 0 6 AMV
RT reaction buffer, 6 ml1 0 6 dNTP solution, 4.2 ml 40 mM sodium
pyrophosphate, 1.8 mld H 2O and 2 ml 10 U AMV RT ml
21) was added
to each hybridization reaction, mixed gently and incubated at 42 uC
for 1 h. Reactions were then treated with 2 ml 10 mg RNase A ml
21 at
37 uC for 30 min and extracted twice with phenol/chloroform/
isoamyl alcohol (25:24:1, w/v/v). DNA was precipitated by adding
0.1 vols 3 M sodium acetate, pH 5.5, and 2.5 vols 70% ethanol and
storing at 280 uC for 30 min. Precipitates were centrifuged at room
temperature for 15 min, washed with 70% ethanol and allowed to
air-dry before resuspending in 10 ml stop solution (USB).
Gel analysis was performed by using a 6% polyacrylamide TBE–urea
gel prepared with 6% PAGE/urea and complete buffer solutions
(Ambion). The gel was pre-electrophoresed at 45 W in 16 Tris-
borate-EDTA (TBE) buffer for 30 min. Primer extension samples
(10 ml) were heated at 90 uC for 5 min before loading onto the gel,
and the
32P-labelled sequencing reactions (2 ml) were heated at 75 uC
for 2 min before loading onto the gel. After running the gel at 45 W
in 16 TBE buffer, it was dried under vacuum at 80 uC for 1 h. The
gel was cooled before exposing to a storage phosphor screen cassette
(Molecular Dynamics) at room temperature overnight. Primer
extension products and the DNA sequencing ladder were detected
by using the Storm PhosphorImager 840 (Molecular Dyanmics/GE
Lifesciences).
RESULTS
Although it has been suggested that activation of toxins of
TA pairs could be a viable antibacterial strategy, the success
of such an approach is dependent on the TA system being
present and functional in the bacteria of interest (Williams
& Hergenrother, 2008). The axe–txe operon has been
shown to reside on plasmids within VRE (Moritz &
Hergenrother, 2007a; Rosvoll et al., 2010), although PCR
alone was used to characterize axe–txe in these studies. In
an effort to link axe–txe definitively to plasmid-encoded
vancomycin resistance genes and to establish the function-
ality of axe–txe within VRE, we first sought to characterize
fully an enterococcal plasmid harbouring axe–txe, and to
determine if VRE clinical isolates synthesize the axe–txe
mRNA transcript. For this, a collection of VRE clinical
isolates previously shown to harbour a plasmid with axe–
txe was used (Moritz & Hergenrother, 2007a).
Sequence analysis of pS177
The nucleotide sequence of plasmid pS177 was determined
by shotgun cloning and sequencing, with average coverage
of 12.46. pS177 is a 39032 bp non-conjugative plasmid
isolated from Ent. faecium clinical strain S177. Its DNA
G+C content is 35.5 mol%, consistent with that of other
enterococcal plasmids and genomes (Sletvold et al., 2007).
Nucleotide BLAST analysis of pS177 revealed that 37358 bp
(95.7%) shared significant (99–100%) similarity with
sequences deposited in the GenBank database (Altschul
et al., 1990). Forty ORFs were identified and annotated
based on these known sequences. For ORFs annotated in
the database as hypothetical proteins, BLASTP searches were
performed to assign a putative function for that potential
protein based on amino acid similarity (Altschul et al.,
1990). pS177 has a mosaic structure comprising a pRUM
backbone, two resistance gene cassettes and five inser-
tion elements (Fig. 1, Table 1). Interestingly, pS177 has
12748 bp (32.6%) and 18930 bp (48.4%) in common
with plasmids p5753cA (GenBank accession no. GQ900435)
and p5753cB (GenBank accession no. GQ900487), respect-
ively, both isolated from Ent. faecium.
pS177 shares 12341 bp (31.6%) of its sequence with
pRUM and contains 75% of the total pRUM plasmid
(GenBank accession no. AF50797). It harbours a pRUM-
like replicon consisting of the putative RepA replication
protein observed in various enterococcal plasmids (Grady
& Hayes, 2003; Rosvoll et al., 2010). In addition to genes
encoding stability mechanisms such as plasmid replication
and partitioning, pS177 carries the TA system axe–txe
(Grady & Hayes, 2003). The axe–txe genes and upstream
promoter region share 100% homology with the pRUM
E. M. Halvorsen and others
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& Hayes, 2003). Plasmid pS177 harbours a gene cassette
from Staphylococcus intermedius (GenBank accession no.
AF299292), which confers resistance to streptothricin, strep-
tomycin, kanamycin and erythromycin (Boerlin et al., 2001).
pRUM carries a nearly identical gene cassette in which the
aphA-3 gene encoding kanamycin resistance is truncated
(Grady & Hayes, 2003). The full-length S. intermedius
resistance gene cassette is also carried on the enterococcal
plasmids pRE25 (Schwarz et al., 2001) and p5753cB.
Additionally, vancomycin resistance is encoded by the
VanA-type glycopeptide resistance determinant Tn1546,
observed on many plasmids identified in VRE, includ-
ing plasmids pVEF3 (Sletvold et al., 2008), p5753cA and
pIP816 (GenBank accession no. AM932524). However, the
Tn1546 cassette on pS177 contains the insertion element
IS1251 between vanS and vanH. This unusual vanA cluster
type has been observed previously (Camargo et al., 2004;
Handwerger & Skoble, 1995; Handwerger et al., 1995) and
is also present on the enterococcal plasmid p5753cA, which
carries a truncated vanA-type gene cassette with IS1251 in
the same position as observed in pS177.
Plasmid pS177 shares 12748 bp (32.6%) with p5753cA,
including the putative RelBE TA system homologue from
Ent. faecium, which we designate relBEEf. The ORFs encod-
ing RelBEf and RelEEf were identified based on their
homology with p5753cA, in which their putative gene
products were annotated as hypothetical proteins. A BLASTP
search of the amino acids encoded by relEEf showed up to
100% identity with a variety of Ent. faecium hypothetical
proteins, as well as 53% amino acid identity with the RelE
protein from Lactobacillus antri (Altschul et al., 1990). The
BLASTP search of the amino acids encoded by relBEf resulted
in hits sharing up to 100% homology with other Ent.
faecium hypothetical proteins, as well as 79% amino acid
identity with the Ent. faecalis AbrB family antitoxin
component.
Transcription of axe–txe in VRE clinical isolates
To determine whether the mRNA transcript coding for the
Axe–Txe proteins is produced in VRE strains previously
shown by PCR to carry axe–txe (Moritz & Hergenrother,
2007a), RT-PCR was performed from total mRNA isolated
from six VRE clinical isolates. As shown in Fig. 2(a), all six
isolates (C29113, S34, S177, SL242, SL266 and SL745)
produce the axe–txe transcript. RT-PCR analysis was also
performed on total RNA isolated from the plasmid-free
Ent. faecium strain BM4105-RF, which does not contain
the axe–txe genes, and no axe–txe transcript was detected
(Fig. 2a). To ensure that the observed RT-PCR products
were not due to DNA contamination, controls were
performed in which the reverse transcriptase enzyme was
not added, but all other components (including thermo-
stable DNA polymerase and primers for axe–txe) were
included. As shown in Fig. 2(b), no amplification product
is observed under these conditions, confirming that the
products seen by RT-PCR were due to the presence of
transcript and not DNA contamination. Finally, RT-PCR
with primers for the enterococcal elongation factor tuf gave
the expected positive result for all seven strains examined
(Fig. 2c) (Garcia-Migura et al., 2007). Thus, RT-PCR
analysis demonstrated that the axe–txe transcript is
synthesized in VRE clinical isolates carrying the axe–txe
genes.
Txe expression inhibits global protein synthesis
As sequencing of pS177 and RT-PCR analysis of six VRE
isolates revealed that axe–txe is present and transcribed in
VRE, we sought to determine the mechanism by which Txe
exerts its toxic activity. Such information could be
exploited in the development of TA-specific antimicrobial
therapies. Txe mechanistic experiments began by assessing
the toxin’s effect on global biosynthetic pathways in the
cell. Radiolabel incorporation assays were carried out with
[
3H]thymidine to measure DNA synthesis, [
3H]uridine to
measure RNA synthesis and [
3H]leucine to measure protein
synthesis upon induction of Txe–His6 expression with
IPTG in E. coli Rosetta BL21(DE3). As shown in Fig. 3(a,
b), levels of DNA and RNA synthesis were not inhibited by
the expression of Txe–His6 in E. coli. In contrast, the level
of proteinsynthesis wassignificantly inhibitedbytheexpres-
sion of Txe–His6 in E. coli (Fig. 3c). By 2 h post-induction,
Fig. 1. Genetic organization and mosaic structure of multidrug-
resistant plasmid pS177. Coding sequences are indicated by
arrows showing the predicted direction of transcription. Position 1
of pS177 was assigned as the same nucleotide position 1 of
pRUM. The origins of the components of pS177 are shown by
black, white or grey arrows: genes from pRUM, black; genes from
p5753cA, white; solitary insertion elements, hatched; VanA-type
glycopeptide resistance gene cassette, dark grey; S. intermedius
resistance gene cassette, light grey.
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3H]leucine incorporation measured was
greatly reduced in cells receiving IPTG compared with cells
that did not receive IPTG. Shorter time points (5, 10, 15 and
30 min) were investigated to determine how quickly
expressionof Txe–His6 inhibited proteinsynthesis; however,
differences in [
3H]leucine incorporation were not observed
Table 1. ORFs of plasmid pS177
ORF* Gene Nucleotide position Protein
length
(aa)
Database match (GenBank accession no.) Amino acid
identity
(%)
5§ 3§
1c prgN 1 291 97 pRUM PrgN (AAO52827) 100
2c orf2 603 980 126 pRUM conserved hypothetical protein, Ent. faecium (AAO52828) 100
3c uvrA 946 2271 442 pRUM UvrA, structural gene for UV resistance (AAO52829) 100
4 sin 2784 3335 184 pRUM Sin recombinase (AAO52830) 100
5c orf5 3500 4504 335 pRUM hypothetical protein (AAO52831) 100
6c txe 4963 5220 86 pRUM Txe, toxin component of TA system (AAO52832) 100
7c axe 5213 5482 90 pRUM Axe, antitoxin component of TA system (AAO52833) 100
8 orf8 5824 6126 101 pRUM conserved hypothetical protein (AAO52834) 100
9 orf9 6169 6387 73 pRUM conserved hypothetical protein (AAO52835) 100
10 tnp (IS6) 6559 7245 229 pRUM IS6 transposase (AAO52848) 100
11c corA 7536 8924 463 Ent. faecium magnesium/nickel/cobalt transporter CorA
(ZP_05660433)
100
12c int 8989 9942 318 Ent. faecium integrase, catalytic region (ZP_00603158) 100
13c orf13 10026 10156 43 p5753cA hypothetical protein (ADA62235) 100
14 res 10585 11148 188 p5753cA resolvase, N-terminal domain (ADA62236) 100
15 tnp (IS1678) 11336 12655 440 Ent. faecium transposase, IS1678 (AAW32124) 99
16c relEEf 13111 13398 96 Lactobacillus antri RelE-like toxin component of TA system
(ZP_05745775)
53
17c relBEf 13388 13717 110 Ent. faecalis Abr-family antitoxin component of TA system
(ZP_06623423)
79
18 cadE 14022 14351 110 p5753cA cadmium efflux system accessory protein (ADA62239) 100
19c vanZ 14638 15123 162 Tn1546 VanZ, teicoplanin resistance protein (AAA65959) 100
20c vanY 15276 16187 304 Tn1546 VanY, truncated carboxypeptidase (AAA65958) 99
21c vanX 16615 17223 203 Tn1546 VanX, D-Ala–D-Ala dipeptidase (AAA65957) 99
22c vanA 17229 18260 344 Tn1546 VanA, D-Ala–D-Lac ligase (AAA65956) 99
23c vanH 18253 19221 323 Tn1546 VanH, pyruvate dehydrogenase (AAA65955) 100
24 tnp (IS1251) 19553 20845 431 Ent. faecium IS1251-like transposase (AAF73111) 100
25c vanS 20943 22097 385 Tn1546 VanS, truncated histidine kinase (AAA65954) 100
26c vanR 22075 22770 232 Tn1546 VanR, regulator of two-component regulatory system
(AAA65953)
100
27c res 22984 23559 192 Tn1546 resolvase (AAA65952) 100
28 tnp (Tn1546) 23705 25856 717 Tn1546 transposase (AAA65951) 100
29 tnp (IS6) 26661 27347 229 pRUM IS6 transposase (AAO52854) 100
30c aph-3 28195 28980 262 S. intermedius Aph-3, aminoglycoside phosphotransferase
(AAG42234)
100
31c sat4 29082 29612 177 S. intermedius Sat4, streptothricin acetyltransferase (AAG42233) 100
32c aadE 29621 30529 303 S. intermedius AadE, streptomycin adenyltransferase (AAG42232) 100
33c MTase 30562 31296 245 Ent. faecium methyltransferase (ZP_00603123) 100
34c dnaP 31277 32146 290 Ent. faecium DNA polymerase, beta-like region (ZP_00603124) 100
35c tnp (IS1182) 32521 33195 225 S. intermedius transposase, IS1182 (AAG42229) 99
36c orf36 33652 33783 44 S. intermedius orf3 (AAG42228) 100
37c ermB 33788 34525 246 S. intermedius ErmB, erythromycin resistance methylase (AAG42227) 100
38 tnp (IS6) 34873 35559 229 pRUM IS6 transposase (AAO52854) 100
39c repA 36175 37215 347 pRUM putative RepA replication protein (AAO52855) 100
40c orf40 37564 37890 109 pRUM hypothetical protein (AAO52856) 100
41c soj 37877 38680 268 pRUM Soj partitioning protein (AAO52857) 100
*ORFs predicted to be transcribed on the complementary strand are denoted with ‘c’.
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available with the online version of this paper). Growth of
E. coli harbouring the pET21a-txe-His6 plasmid in liquid
culture was also examined; induction of Txe–His6 expres-
sion with IPTG in E. coli resulted in a decrease in the viable
cell count (Supplementary Fig. S2).
To determine whether the inhibition of protein synthesis
observed was specific for the expression of Txe–His6,
radiolabel incorporation assays were performed with
[
3H]leucine and E. coli carrying the pET21a-axe-His6
plasmid or the empty pET21a vector. As shown in
Supplementary Fig. S3(a, b), the level of protein synthesis
was not inhibited by the expression of Axe–His6 in E. coli
or when IPTG was added to cells carrying the empty vector.
A direct comparison of levels of [
3H]leucine incorporation
following addition of IPTG to E. coli with pET21a, pET21a-
axe-His6 and pET21a-txe-His6 at the various time points
examined indicated that there is considerable inhibition of
protein synthesis by Txe–His6 (Fig. 4).
Txe inhibits protein synthesis in a cell-free system
A cell-free system was used to examine further the
inhibitory effect of Txe–His6 on protein synthesis. An E.
coli T7 S30 extract system was preincubated with the
pET21a-txe-His6 plasmid to begin synthesis of the Txe–
His6 protein, followed by the addition of DNA encoding
the reporter (pET28a-relB-His6 or pRSF1b-His6-lpp)t o
allow synthesis of RelB–His6 (the antitoxin of the RelBE TA
system) or the major lipoprotein, Lpp, of the E. coli outer
membrane (Christensen & Gerdes, 2003; Gotfredsen &
Gerdes, 1998). Txe–His6 inhibited the synthesis of RelB–
His6 (Fig. 5a, lane 3) and His6–Lpp (Fig. 5b, lane 3). When
His6–Axe or Axe–His6 was synthesized instead of Txe–His6,
protein synthesis of RelB–His6 and His6–Lpp was not
inhibited (Fig. 5a, b, lane 4). Interestingly, both tagged
versions of the antitoxin were unable to significantly
prevent protein synthesis inhibition by Txe–His6 (data not
shown). This may be the result of Txe–His6 inhibiting
protein synthesis of the antitoxin as well as RelB–His6 and
His6–Lpp, or interference of the His6-tag on Axe with its
ability to bind the toxin.
Txe cleaves mRNA in a sequence-specific manner
In vivo primer extension analysis was used to determine if
Txe-mediated protein synthesis inhibition is achieved via
mRNA cleavage in the cell. Cleavage of the 59 end of lpp
mRNA was chosen for analysis given its frequent use as an
RNA substrate for both Northern blot analysis and primer
extension analysis in mechanistic investigations of other
TA system toxins (Christensen-Dalsgaard & Gerdes, 2008;
Christensen & Gerdes, 2003; Christensen et al., 2003;
Zhang et al., 2004).
To perform primer extension analysis in cell culture, RNA
was isolated from E. coli Rosetta BL21(DE3) cultures before
and after induction of txe expression by IPTG. As shown in
Fig. 6, induction of Txe–His6 expression led to the
disappearance of the full-length lpp mRNA band and the
appearance of a major cleavage band as early as 30 min
post-induction (Fig. 6). The major cleavage band appeared
three bases downstream of the A of the AUG start codon.
These results suggest that Txe–His6 cleaves mRNA and that
this RNase activity may lead to the protein synthesis
inhibition observed upon induction of Txe–His6 expres-
sion in the macromolecular synthesis assays and cell-free
protein synthesis assays.
DISCUSSION
The Axe–Txe TA system was first discovered on a
multidrug-resistant plasmid, pRUM, in a vancomycin-
resistant Ent. faecium clinical isolate (Grady & Hayes,
2003). Axe–Txe was one of the first proteic TA systems to
be characterized from Gram-positive bacteria; it was also
notable in that axe–txe was discovered on a bacterial
Fig. 2. RT-PCR analysis of six VRE isolates
and a plasmid-free enterococcal strain
(BM4105-RF). The VRE isolates tested were
C29113, S34, S177, SL242, SL266 and
SL745. (a) RT-PCR with primers complemen-
tary to axe–txe (product size5447 bp). (b)
Controls for DNA contamination, in which
reverse transcriptase was omitted from the
reaction mix. (c) RT-PCR with primers com-
plementary to the enterococci tuf gene (prod-
uct size5112 bp). Lane M, DNA molecular
mass markers.
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bacterial chromosomes. Preliminary analysis of Axe–Txe
demonstrated that it functions as a characteristic TA
system: expression of Txe is toxic to cells, expression of Axe
alleviates Txe-induced toxicity and Axe–Txe increases the
segregational stability of plasmids (Grady & Hayes, 2003).
Due to the prevalence of the axe–txe genes encoded on
plasmids in enterococcal isolates (Moritz & Hergenrother,
2007a; Rosvoll et al., 2010), activation of Txe presents
an attractive antimicrobial strategy. However, a lack of
biochemical characterization of the Axe–Txe proteins,
including knowledge of the biological target or mechanism
of action of Txe, hampers exploration of Axe–Txe as an
antimicrobial target.
In this study, the complete nucleotide sequence of the
39 kb non-conjugative plasmid pS177 isolated from a VRE
clinical strain S177 was determined. A BLAST analysis
revealed extensive homology to known sequences, includ-
ing the enterococcal plasmid pRUM, the vanA-type
glycopeptide resistance determinant Tn1546 and the S.
intermedius resistance gene cassette (Altschul et al., 1990).
Thus, pS177 appears to have arisen from multiple recom-
bination events between smaller plasmids and mobile
genetic elements. This is the first report, to our knowledge,
of a completely sequenced VRE plasmid that harbours a
full-length vanA cassette containing the insertion element
IS1251 between vanS and vanH. Additionally, plasmid
pS177 confers resistance to vancomycin, kanamycin, strep-
tomycin, streptothricin and erythromycin and, indeed,
VRE strain S177 was resistant to gentamicin, erythromycin
and vancomycin (Moritz & Hergenrother, 2007a). The
presence of TA systems on pS177, including axe–txe and
relBEEf, probably enhances plasmid stability and enables
the persistence of this multidrug-resistant plasmid in
clinical isolates of VRE. This is also the first report of a
completely sequenced plasmid carrying both the VanA-
Fig. 3. DNA, RNA and protein synthesis following IPTG induction
of Txe–His6, as assessed immediately before and following
addition of 0 (grey bars) or 0.05 (black bars) mM IPTG to E. coli
Rosetta BL21(DE3) carrying the pET21a-txe-His6 plasmid.
Incorporation of [
3H]thymidine (a), [
3H]uridine (b) and [
3H]leucine
(c). Results are the mean of three independent experiments. Error
bars, SD; P, statistical significance between designated groups.
Fig. 4. Protein synthesis following IPTG induction of Txe–His6,
Axe–His6 and empty pET21a vector. Incorporation of [
3H]leucine
immediately before and following addition of 0.05 mM IPTG to E.
coli Rosetta BL21(DE3) carrying pET21a, pET21a-txe-His6 or
pET21a-axe-His6. Results are the mean of three independent
experiments. Error bars, SD; P, statistical significance between
designated groups.
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shown here for the first time to our knowledge that the
axe–txe transcript is produced in VRE clinical isolates. The
conclusive link between the pRUM-like replicon, axe–txe,
the vanA-type resistance determinant (as demonstrated
from sequencing) and the presence of axe–txe transcripts in
VRE clinical isolates further supports the importance
of axe–txe in the maintenance of plasmids coding for
multidrug resistance, and bolsters the notion of target-
ing axe–txe for antimicrobial development (Moritz &
Hergenrother, 2007b; Rosvoll et al., 2010).
Txe shares significant sequence similarity withthe YoeB toxin,
which ispart of the RelE toxin superfamily, and is structurally
related to the archaeal RelE monomer (Francuski & Saenger,
2009; Kamada, 2005). The RelE and YoeB toxins from E. coli
and two YoeB homologues in Staphylococcus aureushave been
shown to inhibit protein synthesis through mRNA cleavage
(Grady & Hayes, 2003; Zhang & Inouye, 2009; Yoshizumi
et al., 2009; Kamada, 2005). The results of the macromole-
cular synthesis assays and cell-free protein synthesis assays
described herein indicate that Txe significantly inhibits
protein synthesis. The results of primer extension analysis
indicate that Txe cleaves mRNA, and this activity is probably
the mechanism by which Txe inhibits protein synthesis.
The two major mechanisms of action for toxins of TA
systems are the inhibition of DNA gyrase and the cleavage
of cellular RNA. There is reasonable amino acid sequence
similarity between Txe and the YoeB RNase (Grady &
Hayes, 2003); however, it has been noted that these two
toxins have very different effects on cells, with yoeB
expression dramatically reducing viable cell numbers,
whereas txe expression halts growth but does not induce
death (Grady & Hayes, 2003). Although structural and
sequence similarity to other toxins can be informative in
discerning mode of action, it can be misleading as well. For
example, significant structural similarity exists between the
gyrase poison CcdB and the RNase MazF (Buts et al.,
2005). Thus, it was not obvious a priori under which
category Txe would fall.
With the completion of the experiments described herein,
it is now apparent that Txe is an RNase harbouring
similarities to YoeB and sharing some, but not all,
characteristics with other members of the RelE superfamily.
Txe cleaved lpp mRNA three bases downstream of the A of
the AUG start codon, similar to what has been observed
with the YoeB toxin (Yoshizumi et al., 2009; Zhang &
Inouye, 2009). In contrast, the RelE toxin has been shown
to cleave mRNA at both sense and stop codons, with a
strong preference for cleavage of the stop codon UAG
between the second and third bases (Christensen & Gerdes,
2003; Pedersen et al., 2003).
The data presented here indicate that the Txe toxin is an
RNase and inhibits protein synthesis, activities which may
play a role in the ability of axe–txe to stabilize plasmids in
Fig. 5. Effect of Txe–His6, Axe–His6 and His6–
Axe on cell-free protein synthesis. (a) Western
blot with HisProbe–HRP of cell-free protein
synthesis reactions with no DNA added (lane
1), pET28a-relB-His6 DNA added (2), pET28a-
relB-His6 and pET21a-txe-His6 DNA added
(3), and pET28a-relB-His6 and pET21a-axe-
His6 DNA added (4). (b) Western blot with
HisProbe-HRP of cell-free protein synthesis
reactions with no DNA added (lane 1),
pRSF1b-His6-lpp DNA added (2), pRSF1b-
His6-lpp and pET21a-txe-His6 DNA added (3),
and pRSF1b-His6-lpp and pACYCDuet1-His6-
axe DNA added (4). M, Marker lane.
Fig. 6. Txe-induced cleavage of lpp mRNA. The 59 end of lpp
mRNA was mapped by using the primer lpp 21. Numbers indicate
times (min) at which mRNA was harvested after the addition of
IPTG. The major cleavage site is indicated by an arrow. The
sequence around the major cleavage site is shown to the side, with
the cleavage site again indicated by an arrow.
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antibiotic resistance (Grady & Hayes, 2003). As axe–txe
appears to be widespread in VRE clinical isolates (Moritz &
Hergenrother, 2007a; Rosvoll et al., 2010), the artificial
activation of Txe could be an effective antibacterial
strategy.
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